Rheumatoid arthritis

Prevalence and clinical characteristics of patients with rheumatoid arthritis with interstitial lung disease using unstructured healthcare data and machine learning

RMD OpenPublished Retrospective case-control study

Authors' conclusion

We found an estimated age-adjusted prevalence of RA and RAILD by analysing real-world data through NLP. RAILD patients were more vulnerable at the time of inclusion with higher comorbidity and inflammatory burden than RAnonILD, which correlated with higher mortality.

Study context

Population
Adult patients with rheumatoid arthritis (RA) from nine hospitals in Spain, 2014–2019; source population of 3,176,165 patients and 64,241,683 electronic health records (EHRs)patients with RA
Participants
13,958 patients
Comparison
RA with interstitial lung disease (ILD) vs RA without ILD
Outcome
Prevalence of RA and RAILD
Methodological detailsobservational, multicentre, natural language processing of EHR
  • Observational
  • Multicentre
  • Natural language processing of EHR

Main finding

As reported in the abstract

Age-adjusted prevalence

Overall age-adjusted prevalence of RA

0.53%

Overall age-adjusted prevalence of RAILD

0.02%

Proportion of RA patients with ILD (RAILD)

5.1%

Observational data: associations, not effects.

Further findings

Infections

P < 0.001

Malignancies

P < 0.001

CVD

P < 0.001

OutcomeHR (95% CI)P value
Death (in-hospital mortality)2.32 (1.59–2.81)P < 0.001

Most common ILD subtype: usual interstitial pneumonia

Usual interstitial pneumonia
29.3%

Age, comorbidities and inflammatory burden

RAILD patients were older, had more comorbidities, more pharmacological prescriptions and higher inflammatory parameters than RAnonILD

Original publication

Prevalence and clinical characteristics of patients with rheumatoid arthritis with interstitial lung disease using unstructured healthcare data and machine learning. RMD Open. Published 30 January 2024. doi:10.1136/rmdopen-2023-003353

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.